160 related articles for article (PubMed ID: 7543232)
41. D2-40 is not a specific marker for cells of mesothelial origin in serous effusions.
Bassarova AV; Nesland JM; Davidson B
Am J Surg Pathol; 2006 Jul; 30(7):878-82. PubMed ID: 16819331
[TBL] [Abstract][Full Text] [Related]
42. Differentiation of mesothelioma from adenocarcinoma in serous effusions: the role of hyaluronic acid and CD44 localization.
Afify AM; Stern R; Michael CW
Diagn Cytopathol; 2005 Mar; 32(3):145-50. PubMed ID: 15690337
[TBL] [Abstract][Full Text] [Related]
43. Immunohistochemical properties of malignant mesothelioma cells in histologic and cytologic specimens.
Motoyama T; Watanabe T; Okazaki E; Tanaka N; Watanabe H
Acta Cytol; 1995; 39(2):164-70. PubMed ID: 7534025
[TBL] [Abstract][Full Text] [Related]
44. Monoclonal antibodies in the cytodiagnosis of serous effusions.
al-Nafussi A; Carder PJ
Cytopathology; 1990; 1(2):119-28. PubMed ID: 1714782
[TBL] [Abstract][Full Text] [Related]
45. The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2.
Attanoos RL; Griffin A; Gibbs AR
Histopathology; 2003 Sep; 43(3):231-8. PubMed ID: 12940775
[TBL] [Abstract][Full Text] [Related]
46. The distinction of adenocarcinoma from malignant mesothelioma in cell blocks of effusions: the role of routine mucin histochemistry and immunohistochemical assessment of carcinoembryonic antigen, keratin proteins, epithelial membrane antigen, and milk fat globule-derived antigen.
Cibas ES; Corson JM; Pinkus GS
Hum Pathol; 1987 Jan; 18(1):67-74. PubMed ID: 2434407
[TBL] [Abstract][Full Text] [Related]
47. Platelet-derived growth factor receptor alpha subunit deleted Patch mouse exhibits severe cardiovascular dysmorphogenesis.
Schatteman GC; Motley ST; Effmann EL; Bowen-Pope DF
Teratology; 1995 Jun; 51(6):351-66. PubMed ID: 7502236
[TBL] [Abstract][Full Text] [Related]
48. Primary papillary serous tumor of the peritoneum. Report of a case.
Boldorini R; Cristina S
Pathologica; 1992; 84(1091):403-9. PubMed ID: 1281538
[TBL] [Abstract][Full Text] [Related]
49. The cytopathology of mesothelioma.
Tao LC
Acta Cytol; 1979; 23(3):209-13. PubMed ID: 294056
[TBL] [Abstract][Full Text] [Related]
50. Immunophenotyping of mesothelial cells and carcinoma cells with monoclonal antibodies to cytokeratins, vimentin, CEA and EMA improves the cytodiagnosis of serous effusions.
Daste G; Serre G; Mauduyt MA; Vincent C; Caveriviere P; Soleilhavoup JP
Cytopathology; 1991; 2(1):19-28. PubMed ID: 1715202
[TBL] [Abstract][Full Text] [Related]
51. Immunohistochemical distribution patterns of epidermal growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.
Ramael M; Segers K; Buysse C; Van den Bossche J; Van Marck E
Virchows Arch A Pathol Anat Histopathol; 1991; 419(3):171-5. PubMed ID: 1926758
[TBL] [Abstract][Full Text] [Related]
52. Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium.
Ramael M; Lemmens G; Eerdekens C; Buysse C; Deblier I; Jacobs W; van Marck E
J Pathol; 1992 Dec; 168(4):371-5. PubMed ID: 1484318
[TBL] [Abstract][Full Text] [Related]
53. An unusual cytologic presentation of mesothelioma in serous effusions.
Spriggs AI; Grunze H
Acta Cytol; 1983; 27(3):288-92. PubMed ID: 6575546
[TBL] [Abstract][Full Text] [Related]
54. [Value of immunocytochemistry in differential diagnosis of gastric adenocarcinoma, reactive mesothelial cells and malignant epithelial mesothelioma in metastatic effusion fluid].
Lyu M; Cha N; Zou YF; Leng JH; Xu L; Sun Y; Hao YY
Zhonghua Bing Li Xue Za Zhi; 2018 Mar; 47(3):180-185. PubMed ID: 29534357
[No Abstract] [Full Text] [Related]
55. Coexpression of simple epithelial keratins and vimentin by human mesothelium and mesothelioma in vivo and in culture.
LaRocca PJ; Rheinwald JG
Cancer Res; 1984 Jul; 44(7):2991-9. PubMed ID: 6202404
[TBL] [Abstract][Full Text] [Related]
56. Establishment and characterization of five human malignant mesothelioma cell lines derived from pleural effusions.
Manning LS; Whitaker D; Murch AR; Garlepp MJ; Davis MR; Musk AW; Robinson BW
Int J Cancer; 1991 Jan; 47(2):285-90. PubMed ID: 1703129
[TBL] [Abstract][Full Text] [Related]
57. Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies.
Zeng L; Fleury-Feith J; Monnet I; Boutin C; Bignon J; Jaurand MC
Hum Pathol; 1994 Mar; 25(3):227-34. PubMed ID: 7512071
[TBL] [Abstract][Full Text] [Related]
58. Paradoxical effects of platelet-derived growth factor-A overexpression in malignant mesothelioma. Antiproliferative effects in vitro and tumorigenic stimulation in vivo.
Metheny-Barlow LJ; Flynn B; van Gijssel HE; Marrogi A; Gerwin BI
Am J Respir Cell Mol Biol; 2001 Jun; 24(6):694-702. PubMed ID: 11415934
[TBL] [Abstract][Full Text] [Related]
59. [Expression of platelet-derived growth factor receptor α and its ligand PDGF- A in breast cancer].
Liu DS; Zhang XJ; Chen G; Lu CF; Dong HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):313-4, 316. PubMed ID: 21638928
[TBL] [Abstract][Full Text] [Related]
60. Distinction between cells in serous effusions using a panel of antibodies.
Lauritzen AF
Virchows Arch A Pathol Anat Histopathol; 1987; 411(3):299-304. PubMed ID: 2441518
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
